SCHEMBL3533602

SCHEMBL3533602

Nc1ccc(N2CCSCC2)cc1N1CCCCC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 5/20 0.87
ALDH1A1 P00352 7/20 0.83
MAPT P10636 6/20 0.83
HTT P42858 6/20 0.83
GAA P10253 4/20 0.83
MAPK1 P28482 3/20 0.83
L3MBTL1 Q9Y468 3/20 0.83
LMNA P02545 3/20 0.83
S100B P04271 2/20 0.83
MEN1 O00255 2/20 0.83
ALOX15 P16050 2/20 0.83
KMT2A Q03164 2/20 0.83
PKM P14618 1/20 0.83
TDP1 Q9NUW8 1/20 0.83
KDM4E B2RXH2 3/20 0.58
RECQL P46063 2/20 0.58
PTK2B Q14289 1/20 0.58
KEAP1 Q14145 1/20 0.49
IP6K1 Q92551 1/20 0.47
POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3538453 0.91 ALDH1A1 (1.00) LGMNALDH1A1MAPTHTTGAA
SCHEMBL3536844 0.82 LGMN (0.87) LGMNALDH1A1MAPTHTTGAA
SCHEMBL3533660 0.82 MAPT (0.87) LGMNALDH1A1MAPTHTTGAA
SCHEMBL31000427 0.82 MAPT (0.87) LGMNALDH1A1MAPTHTTGAA
Hydrochloric Acid SCHEMBL3539659 0.81 MAPT (0.84) LGMNALDH1A1MAPTHTTGAA
Hydrochloric Acid SCHEMBL30501445 0.81 LGMN (0.84) LGMNALDH1A1MAPTHTTGAA
SCHEMBL20440550 0.80 LGMN (0.76) LGMNALDH1A1MAPTHTTGAA
SCHEMBL9073400 0.80 MAPT (0.77) LGMNALDH1A1MAPTHTTGAA
SCHEMBL12490848 0.80 ALDH1A1 (0.56) LGMNALDH1A1MAPTHTTGAA
Hydrochloric Acid SCHEMBL20598232 0.80 LGMN (0.82) LGMNALDH1A1MAPTHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US claimed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES LGMN 3741/4885ALDH1A1 4796/4885MAPT 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.